0
We're unable to sign you in at this time. Please try again in a few minutes.
Retry
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
Retry
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
Editor's Correspondence |

Activated Partial Thromboplastin Time vs Heparin Concentration

Brian A. Baker, PharmD; Michael D. Adelman, MD
Arch Intern Med. 1998;158(11):1273-1275. doi:.
Text Size: A A A
Published online

Extract

In reply

There are 2 major issues concerning heparin monitoring. As stated in our article and reemphasized by Mungall, the first is the ability to generalize results from previous trials. This requires the ability to achieve degrees of anticoagulation similar to those reported in earlier studies. The second issue involves optimizing heparin therapy.

Mungall references studies that used the activated partial thromboplastin time (aPTT) ratio to adjust heparin therapy as evidence to support this method of heparin monitoring. This presumes that an aPTT ratio adequately adjusts for the variability of different reagents. Of the 5 studies Mungall cites that used an aPTT ratio 1.5 to 2.5 times that of controls,15 3 of these actually used an aPTT ratio of 1.5 to 2.0 with no evidence provided by the authors24 that the aPTT ratio was established using heparin levels. The study by Hull et al5 used an aPTT ratio of 1.57 to 2.14, which was determined by protamine titration to correspond to heparin levels of 0.2 to 0.4 U/mL. As noted by Hirsh,6 "Because the slopes of the lines describing the relation between the aPTT and heparin levels with different reagents may not be parallel, responsiveness may not be standardized by expressing the aPTT result as a ratio." Brill-Edwards et al7 reported therapeutic aPTT ratios for 4 reagents corresponding to therapeutic heparin levels of 0.2 to 0.4 U/mL by protamine titration. These ratios were 2.3 to 3.0, 2.0 to 2.6, 1.8 to 2.5, and 1.9 to 2.5, respectively. Given this variation in aPTT ratios for different reagents, one cannot be certain that the degree of anticoagulation achieved in an individual patient is the same as that achieved in a reported trial based on the aPTT ratios.

Sign in

Create a free personal account to sign up for alerts, share articles, and more.

Purchase Options

• Buy this article
• Subscribe to the journal

First Page Preview

View Large
First page PDF preview

First Page Preview

View Large
First page PDF preview

Figures

Tables

References

Correspondence

June 8, 1998
Brian A. Baker, PharmD; Michael D. Adelman, MD
Arch Intern Med. 1998;158(11):1273-1275. doi:.
CME
Also Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
Your answers have been saved for later.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.
Submit a Comment

Multimedia

Some tools below are only available to our subscribers or users with an online account.

Sign in

Create a free personal account to sign up for alerts, share articles, and more.

Purchase Options

• Buy this article
• Subscribe to the journal

Related Content

Customize your page view by dragging & repositioning the boxes below.

See Also...
Articles Related By Topic
Related Collections
PubMed Articles
Jobs
JAMAevidence.com

Users' Guides to the Medical Literature
Clinical Scenario

Users' Guides to the Medical Literature
Back to the Clinical Scenario—Part 1

brightcove.createExperiences();